Biomarkers in the Era of Precision Oncology

Cancers (Basel). 2023 Mar 15;15(6):1782. doi: 10.3390/cancers15061782.

Abstract

Cancer heterogeneity provides a formidable obstacle to optimizing clinical protocols to achieve durable clinical responses [...].

Publication types

  • Editorial